5Jin M, Casper T C, Cataland S R, et al. Relationship be- tween ADAMTS13 activity in clinical remission and the risk of ITP relapse[ J]. Br J Haematol, 2008,141 (5) :651-658.
6Crowther M A, George J N. Thrombotic thrombocytopenic purpura: 2008 update[J]. Cleve Clin J Med, 2008,75(5): 369-375.
7Frawley N, Ng A P, Nicholls K, et al. Thrombotic thrombo- cytopenic purpura is associated with a high relapse rate after plasma exchange : a single-centre experience[ J 1. Intern Med J, 2009,39(1) :19-24.
8Aqui N A, Stein S H, Konkle B A, et al. Role of splenecto- my in patients with refractory or relapsed thrombotic throm- bocytopenic purpura[J]. J Clin Apher, 2003,18(2):51-54.
9Bucciarelli S, Cervera R, Espinosa G, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors [ J ]. Autoimmun Rev, 2006,6 (2) :72-75.
10Asherson R A. The catastrophic antiphospholipid (Asherson's) syndrome [ J ]. Autoimmun Rev, 2006,6 (2) :64-67.
